Kalaris Therapeutics Inc. (KLRS) vs XBiotech Inc. (XBIT)
Kalaris Therapeutics Inc. and XBiotech Inc. are both Biotechnology companies. Kalaris Therapeutics Inc. and XBiotech Inc. are of similar size ($67.1M and $65.9M). Across the 10 metrics below, XBiotech Inc. leads on 6 and Kalaris Therapeutics Inc. on 4.
Valuation
Profitability
| Metric | KLRS | XBIT | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (79.91%) | (29.94%) | (57.72%) |
| Return on assets | (46.02%) | (28.90%) | (49.22%) |
| Return on invested capital | 0.00% | (159.18%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack